Browsing MED_Articles by Author "e221c78b-90dd-459a-b16d-4aee97b16972"

Now showing items 1-3 of 3

    • openAccess   Clinical characteristics, treatment, and blood pressure control in patients with hypertension seen by primary care physicians in Spain: the IBERICAN study 

      PRIETO-DIAZ, MIGUEL ANGEL; Pallarés-Carratalá, Vicente; MICÓ PÉREZ, RAFAEL MANUEL; Escobar, Carlos; Martin, Vicente; Antonio, Coca; barquilla garcía, alfonso; Velilla-zancada, Sonsoles; Polo-García, J.; Segura Fragoso, Antonio; Ginel-Mendoza, Leovigildo; Hermida-Ameijeiras, Alvaro; Cinza-Sanjurjo, Sergio Frontiers Media (2023)
      Objectives: To determine the clinical profile, according to the history of hypertension, the risk of developing hypertension, current antihypertensive treatment and BP control rates in patients with hypertension from the ...

    • openAccess   Elevated pulse pressure and cardiovascular risk associated in Spanish population attended in primary care: IBERICAN study 

      Moyá Amengual, Ana; Ruiz-Garcia, Antonio; Pallarés-Carratalá, Vicente; Serrano-Cumplido, Adalberto; Prieto-Díaz, Miguel Ángel; Segura Fragoso, Antonio; Cinza-Sanjurjo, Sergio Frontiers Media (2023)
      Introduction: Elevated pulse pressure (ePP) is an independent marker of cardiovascular risk (CVR) in people older than 60, and a functional marker of subclinical target organ damage (sTOD) which can predict cardiovascular ...

    • openAccess   Prevalence of Hyperuricemia and Its Association with Cardiovascular Risk Factors and Subclinical Target Organ Damage 

      Antelo Pais, Paula; PRIETO-DIAZ, MIGUEL ANGEL; MICÓ PÉREZ, RAFAEL MANUEL; Pallarés-Carratalá, Vicente; Velilla-zancada, Sonsoles; Polo García, José Luis; barquilla garcía, alfonso; Ginel-Mendoza, Leovigildo; Segura Fragoso, Antonio; Vitelli-Storelli, Facundo; Martin, V.; Hermida-Ameijeiras, Alvaro; Cinza-Sanjurjo, Sergio MDPI (2022-12-21)
      The role of uric acid levels in the cardiovascular continuum is not clear. Our objective is to analyze the prevalence of hyperuricemia (HU) and its association with cardiovascular risk factors (CVRF), subclinical target ...